Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

14.45
Delayed Data
As of Mar 24
 +0.35 / +2.48%
Today’s Change
7.20
Today|||52-Week Range
18.00
-9.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues33.9M50.2M109.9M146.0M
 
 
 
 
 
Cost of Goods Sold0.001.6M22.9M23.8M
 
 
 
 
Depreciation And Amortization1.9M2.8M13.6M11.9M
 
 
 
 
 
 
Operating ExpensesGross Income32.0M45.8M73.5M110.4M
 
 
 
 
 
General Expenses52.4M102.7M113.7M128.9M
 
 
 
 
 
Research And Development28.0M19.2M29.1M29.2M
 
 
 
 
 
Total Operating Expenses54.3M107.1M150.1M164.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.4M-57.0M-40.2M-18.6M
 
 
 
 
 
Extraordinary Credit0.0077.6M0.000.00
 
 
Extraordinary Charge0.00-600.0K0.000.00
 
 
Other Expenses145.0K124.0K320.0K665.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.3M20.2M-39.9M-17.9M
 
 
 
 
 
Income Taxes0.000.000.00-104.0K
 
 
Net Income-20.3M20.2M-39.9M-18.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS30.4M34.8M42.3M43.4M
 
 
 
 
 
Shares To Calculate EPS Diluted30.4M36.7M42.3M43.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.67$0.55-$0.94-$0.41
 
 
 
 
 
EPS Diluted-$0.67$0.55-$0.94-$0.41